AcquisitionOther
Collegium Pharmaceutical acquired AZSTARYS
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Collegium Pharmaceutical -> AZSTARYS · $650 million
“We are pleased to complete the acquisition of AZSTARYS, a highly strategic addition to our portfolio that strengthens our position in ADHD and further reinforces our long-standing commitment to improving patient care and delivering shareholder value,” said Vikram Karnani, President and Chief Executive Officer
Open source record (SEC) ↗